These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 27363619)

  • 1. CXCR4 signaling in health and disease.
    Pozzobon T; Goldoni G; Viola A; Molon B
    Immunol Lett; 2016 Sep; 177():6-15. PubMed ID: 27363619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12/CXCR4-axis dysfunctions: Markers of the rare immunodeficiency disorder WHIM syndrome.
    Bachelerie F
    Dis Markers; 2010; 29(3-4):189-98. PubMed ID: 21178277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome.
    Lagane B; Chow KY; Balabanian K; Levoye A; Harriague J; Planchenault T; Baleux F; Gunera-Saad N; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2008 Jul; 112(1):34-44. PubMed ID: 18436740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.
    Balabanian K; Lagane B; Pablos JL; Laurent L; Planchenault T; Verola O; Lebbe C; Kerob D; Dupuy A; Hermine O; Nicolas JF; Latger-Cannard V; Bensoussan D; Bordigoni P; Baleux F; Le Deist F; Virelizier JL; Arenzana-Seisdedos F; Bachelerie F
    Blood; 2005 Mar; 105(6):2449-57. PubMed ID: 15536153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) syndrome.
    Dotta L; Tassone L; Badolato R
    Curr Mol Med; 2011 Jun; 11(4):317-25. PubMed ID: 21506920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR4-Specific Nanobodies as Potential Therapeutics for WHIM syndrome.
    de Wit RH; Heukers R; Brink HJ; Arsova A; Maussang D; Cutolo P; Strubbe B; Vischer HF; Bachelerie F; Smit MJ
    J Pharmacol Exp Ther; 2017 Oct; 363(1):35-44. PubMed ID: 28768817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation.
    Sanmun D; Garwicz D; Smith CI; Palmblad J; Fadeel B
    Br J Haematol; 2006 Sep; 134(6):640-4. PubMed ID: 16899028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.
    Murphy PM; Heusinkveld L
    Cytokine; 2018 Sep; 109():2-10. PubMed ID: 29398278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 mutations in WHIM syndrome: a misguided immune system?
    Diaz GA
    Immunol Rev; 2005 Feb; 203():235-43. PubMed ID: 15661033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G protein-coupled receptor kinase-3-deficient mice exhibit WHIM syndrome features and attenuated inflammatory responses.
    Tarrant TK; Billard MJ; Timoshchenko RG; McGinnis MW; Serafin DS; Foreman O; Esserman DA; Chao NJ; Lento WE; Lee DM; Patel D; Siderovski DP
    J Leukoc Biol; 2013 Dec; 94(6):1243-51. PubMed ID: 23935208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WHIM syndrome: Immunopathogenesis, treatment and cure strategies.
    McDermott DH; Murphy PM
    Immunol Rev; 2019 Jan; 287(1):91-102. PubMed ID: 30565238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CXCR4, a therapeutic target in rare immunodeficiencies?].
    Bignon A; Biajoux V; Bouchet-Delbos L; Emilie D; Lortholary O; Balabanian K
    Med Sci (Paris); 2011 Apr; 27(4):391-7. PubMed ID: 21524404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The complex nature of CXCR4 mutations in WHIM syndrome.
    Rodríguez-Frade JM; González-Granado LI; Santiago CA; Mellado M
    Front Immunol; 2024; 15():1406532. PubMed ID: 39035006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dysfunctions of the CXCL12 (SDF-1)/CXCR4 signaling axis in the WHIM syndrome and the idiopathic CD4(+) T-cell lymphocytopenia].
    Biajoux V; Bignon A; Bouchet-Delbos L; Emilie D; Balabanian K
    Biol Aujourdhui; 2010; 204(4):273-84. PubMed ID: 21215244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchical organization of multi-site phosphorylation at the CXCR4 C terminus.
    Mueller W; Schütz D; Nagel F; Schulz S; Stumm R
    PLoS One; 2013; 8(5):e64975. PubMed ID: 23734232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Filamin A interaction with the CXCR4 third intracellular loop regulates endocytosis and signaling of WT and WHIM-like receptors.
    Gómez-Moutón C; Fischer T; Peregil RM; Jiménez-Baranda S; Stossel TP; Nakamura F; Mañes S
    Blood; 2015 Feb; 125(7):1116-25. PubMed ID: 25355818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.
    Kallikourdis M; Trovato AE; Anselmi F; Sarukhan A; Roselli G; Tassone L; Badolato R; Viola A
    Blood; 2013 Aug; 122(5):666-73. PubMed ID: 23794067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CXCR4 as a rheostat of humoral response].
    Khamyath M; Bonaud A; Balabanian K; Espéli M
    Med Sci (Paris); 2023 Jan; 39(1):23-30. PubMed ID: 36692314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent CXCR4 sequence variation in a girl with WHIM syndrome.
    Alapi K; Erdos M; Kovács G; Maródi L
    Eur J Haematol; 2007 Jan; 78(1):86-8. PubMed ID: 17087743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4.
    Kawai T; Choi U; Cardwell L; DeRavin SS; Naumann N; Whiting-Theobald NL; Linton GF; Moon J; Murphy PM; Malech HL
    Blood; 2007 Jan; 109(1):78-84. PubMed ID: 16946301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.